Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

Philadelphia-based Independence Blue Cross has set a benefit exclusion for products that receive accelerated approval from ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

So there really is an active ingredient, but again, they haven’t been evaluated for their efficacy or safety.” But not all ...

On Friday, a grand jury in West Baton Rouge, Louisiana, returned a felony indictment of New York-based Dr. Margaret Carpenter ...

Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...